The ultimate ASX growth shares to buy and hold for the next bull market

Brokers think these shares could be great long term investment options right now.

| More on:
a man in a business suite throws his arms open wide above his head and raises his face with his mouth open in celebration in front of a background of an illuminated board tracking stock market movements.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Markets move in cycles, but one truth always holds: quality businesses tend to emerge stronger when conditions improve.

While some investors may be still sitting on the sidelines waiting for the next clear uptrend, seasoned long-term investors know that the best opportunities often come before the bull market begins. Now is the time to be positioning — not after the rally is already underway.

With that in mind, here are three high-quality ASX growth shares that analysts think could be top buys right now. They are as follows:

Pro Medicus Ltd (ASX: PME)

Pro Medicus has built a global reputation as a healthcare technology powerhouse. Its flagship product, Visage, is a leading radiology imaging platform that enables medical professionals to analyse images faster and more efficiently. This is more than just speed — it's about improving clinical outcomes and reducing healthcare bottlenecks.

The company has consistently delivered strong earnings growth, maintains high margins, and holds long-term contracts with some of the world's most prestigious hospitals. It's founder-led, cash-rich, and has no debt. And while its valuation can look expensive at first glance, this is arguably justified due to its quality and strong long term growth potential.

Goldman Sachs is bullish and has a buy rating and $301.00 price target on its shares.

ResMed Inc. (ASX: RMD)

Another ASX growth share that could be a buy is ResMed. It is a global leader in sleep and respiratory care, best known for its CPAP machines and cloud-connected health platforms.

ResMed operates in a growing global market, supported by ageing populations and increasing awareness of sleep-related health issues. It has also built a powerful digital ecosystem, helping patients and healthcare providers manage treatment more effectively. With strong recurring revenue, a proven leadership team, and global scale, ResMed looks like it has many years of strong growth ahead.

Goldman Sachs is also a big fan of ResMed. It has a conviction buy rating and $49.30 price target on its shares.

Temple & Webster Group Ltd (ASX: TPW)

Finally, Temple & Webster could be an ASX growth share to buy and hold. It is one of Australia's fastest growing retailers, disrupting the furniture and homewares space through a scalable, online-only model. As the shift from traditional to digital retail continues, the company is in the right place at the right time — and executing impressively.

It has built a strong brand, loyal customer base, and an expansive product range. Importantly, it's showing improving operating leverage as it scales — a key factor for long-term profitability. With an asset-light business model, strong marketing capability, and ongoing category expansion, Temple & Webster is positioning itself to be a dominant ecommerce player in the years to come.

Citi is bullish on the company and has a buy rating and $21.10 price target on its shares.

Citigroup is an advertising partner of Motley Fool Money. Motley Fool contributor James Mickleboro has positions in Pro Medicus, ResMed, and Temple & Webster Group. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group, ResMed, and Temple & Webster Group. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has positions in and has recommended ResMed. The Motley Fool Australia has recommended Pro Medicus and Temple & Webster Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

Australian dollar notes in the pocket of a man's jeans, symbolising dividends.
Growth Shares

Where to invest $1,000 into ASX shares in June

These shares could be buys according to analysts.

Read more »

Young female investor smiling and speaking on mobile phone while sitting in front of laptop
Growth Shares

Looking for ASX growth shares? I rate these 2 as top buys for June

I’m very excited about the growth potential of these stocks…

Read more »

Two smiling work colleagues discuss an investment or business plan at their office.
Growth Shares

3 high-conviction ASX growth shares to buy

Analysts have good things to say about these stocks.

Read more »

happy investor, share price rise, increase, up
Growth Shares

Where to invest $5,000 into ASX growth shares now

These shares could be destined for big things according to analysts.

Read more »

ETF spelt out with a piggybank.
ETFs

Want to buy ASX growth shares? Consider these ETFs instead

Growth ETFs can be easier to invest in than shares.

Read more »

A businessman compares the growth trajectory of property versus shares.
Growth Shares

Are these 2 top ASX growth shares buys?

ASX growth shares can deliver strong results. Should these stocks be in your portfolio?

Read more »

A man clenches his fists in excitement as gold coins fall from the sky.
Growth Shares

These ASX growth stocks could rise 80% to 100%

Let's see what brokers are tipping as buys with big return potential.

Read more »

Man holding a tray of burritos, symbolising the Guzman share price.
Share Market News

Wingstop mania hits Sydney — is Guzman y Gomez next in line to soar?

Can Guzman y Gomez be Australia’s next fast food success story on the ASX?

Read more »